Lv3
350 积分 2024-01-08 加入
IGF2BP1-mediated N6-methyladenosine modification promotes intrahepatic cholangiocarcinoma progression
1个月前
已完结
Emerging importance of m6A modification in liver cancer and its potential therapeutic role
1个月前
已完结
Mechanism of METTL3 in the proliferation, invasion, and migration of intrahepatic cholangiocarcinoma cells via m6A modification
1个月前
已完结
N6-Methyladenosine Reader YTHDF1 Promotes Stemness and Therapeutic Resistance in Hepatocellular Carcinoma by Enhancing NOTCH1 Expression
1个月前
已完结
FTO/m6A/GPNMB axis: a novel promising target for hepatocellular carcinoma (HCC) treatment?
1个月前
已完结
Sex Hormone: A Potential Target at Treating Female Metabolic Dysfunction-Associated Steatotic Liver Disease?
1个月前
已关闭
Liver Cancer Risk Across Metabolic Dysfunction-Associated Steatotic Liver Disease and/or Alcohol: A Nationwide Study
1个月前
已完结
Head-to-Head Comparison Between Phosphatidylethanol Versus Indirect Alcohol Biomarkers for Diagnosis of MetALD Versus MASLD: A Prospective Study
1个月前
已完结
MetALD: New Perspectives on an Old Overlooked Disease
2个月前
已完结
MetALD: new opportunities to understand the role of alcohol in steatotic liver disease
2个月前
已完结
皖公网安备34019202002308
